| Median | – | 11.2% | 2.8% | 8.4% | 6.7% | 0.59x |
| LLYEli Lilly · Drug manufacturers | $65.2B | 44.7%▲ | 94.9%▲ | 40.9%▲ | 34.5%▲ | 1.60x▼ |
| JNJJohnson & Johnson · Drug manufacturers | $94.2B | 6%▼ | 90.6%▲ | 35.6%▲ | 23.1%▲ | 0.51x▲ |
| ABBVAbbVie · Drug manufacturers | $61.2B | 8.6%▼ | -1.2%▼ | 24.6%▲ | 16.6%▲ | – |
| MRKMerck · Drug manufacturers | $65.0B | 1.3%▼ | 6.6%▲ | 34.5%▲ | 20.7%▲ | 0.93x▼ |
| UNHUnitedhealth · Healthcare plans | $448B | 11.8%▲ | -16.3%▼ | 4.2%▼ | 9.7%▲ | 0.78x▼ |
| NVSNovartis · Drug manufacturers | $54.5B | 8.4%▼ | 17%▲ | 32.4%▲ | 21.1%▲ | 0.62x▼ |
| AZNAstrazeneca · Drug manufacturers | $58.7B | 8.6%▼ | 45.3%▲ | 23.4%▲ | 16.5%▲ | 0.57x▲ |
| AMGNAMGEN · Biotechnology | $36.8B | 10%▼ | 88.5%▲ | 24.7%▲ | 13.9%▲ | 6.31x▼ |
| GILDGilead Sciences · Biotechnology | $29.4B | 2.4%▼ | 1673%▲ | 34%▲ | 21.2%▲ | 1.10x▼ |
| ABTAbbott Laboratories · Drug manufacturers | $44.3B | 5.7%▼ | -51.3%▼ | 18.2%▲ | 11.5%▲ | 0.25x▲ |
| NVONovo Nordisk A S · Drug manufacturers | DKK 309B | 6.4%▼ | 1.4%▼ | 41.3%▲ | 39%▲ | 0.67x▼ |
| PFEPfizer · Drug manufacturers | $62.6B | -1.6%▼ | -3.2%▼ | – | – | 0.75x▼ |
| ISRGIntuitive Surgical · Medical devices & instruments | $10.1B | 20.5%▲ | 23%▲ | 29.3%▲ | 16%▲ | – |
| VRTXVertex Pharmaceuticals Inc / MA · Drug manufacturers | $12.0B | 8.9%▼ | – | 34.8%▲ | 19.2%▲ | – |
| BMYBristol Myers Squibb · Drug manufacturers | $48.2B | -0.2%▼ | – | 19.4%▲ | 14%▲ | 2.43x▼ |
| MDTMedtronic · Medical devices & instruments | $36.4B | 8.4%▼ | 3%▲ | 17.8%▲ | 7.9%▲ | 0.57x▲ |
| CVSCVS Health · Pharmaceutical retailers | $402B | 7.8%▼ | -61.7%▼ | 1.2%▼ | 2.8%▼ | 0.80x▼ |
| MCKMckesson · Medical distribution | $403B | 12.4%▲ | 44.5%▲ | 1.5%▼ | 40.6%▲ | – |
| SYKStryker · Medical devices & instruments | $25.1B | 11.2% | 8.5%▲ | 19.5%▲ | 12.2%▲ | 0.71x▼ |
| HCAHCA Healthcare · Medical care facilities | $75.6B | 7.1%▼ | 17.8%▲ | 13%▲ | 22.2%▲ | – |
| GSKGSK · Drug manufacturers | GBP 32.7B | 4.1%▼ | 113%▲ | 24.3%▲ | 20%▲ | 1.08x▼ |
| SNYSanofi · Drug manufacturers | EUR 43.6B | 6.2%▼ | 39.7%▲ | 14.5%▲ | 6.4%▼ | 0.26x▲ |
| ELVElevance Health · Healthcare plans | $199B | 12.5%▲ | -5.3%▼ | 3.6%▼ | 8.9%▲ | 0.73x▼ |
| MRNAModerna · Biotechnology | $1.9B | -39.9%▼ | – | -158%▼ | -29.7%▼ | 0.07x▲ |
| MMM3M · Medical devices & instruments | $24.9B | 1.5%▼ | -22.1%▼ | 18.6%▲ | 16.5%▲ | 2.68x▼ |
| REGNRegeneron Pharmaceuticals · Drug manufacturers | $14.3B | 1%▼ | 2.1%▼ | 24.9%▲ | 9.9%▲ | 0.06x▲ |
| CICigna · Healthcare plans | $275B | 11.2%▲ | 73.5%▲ | 3.3%▼ | 9.1%▲ | 0.75x▼ |
| CORCencora · Medical distribution | $321B | 9.3%▼ | 3%▲ | 0.8%▼ | 14%▲ | 5.08x▼ |
| BSXBoston Scientific · Medical devices & instruments | $20.1B | 19.9%▲ | 56.7%▲ | 18%▲ | 9.4%▲ | 0.47x▲ |
| TAKTakeda Pharmaceutical · Drug manufacturers | JPY 4.51T | -1.7%▼ | -241%▼ | 0.1%▼ | 0%▼ | 0.66x▼ |
| NTRANatera · Diagnostics & research | $2.3B | 35.9%▲ | – | -13.4%▼ | -15.8%▼ | – |
| CAHCardinal Health · Medical distribution | $254B | 14.2%▲ | 9.8%▲ | 1%▼ | 19.5%▲ | – |
| ARGXArgenx · Biotechnology | $4.2B | 89.9%▲ | 55.1%▲ | 25.4%▲ | 14.3%▲ | – |
| HUMHumana · Healthcare plans | $130B | 10.1%▼ | -1.6%▼ | 2.1%▼ | 8.3%▲ | 0.70x▼ |
| BDXBecton Dickinson · Medical devices & instruments | $21.8B | 8.2%▼ | -1.6%▼ | 11.8%▲ | 5.5%▼ | 0.76x▼ |
| EWEdwards Lifesciences · Medical devices & instruments | $6.1B | 11.5%▲ | -74.3%▼ | 20.8%▲ | 10.6%▲ | 0.06x▲ |
| AAgilent Technologies · Diagnostics & research | $6.9B | 6.7%▼ | 1.1%▼ | 21.3%▲ | 14.2%▲ | 0.50x▲ |
| MDLNMedline · Medical devices & instruments | $28.4B | 11.5%▲ | -0.3%▼ | 7.8%▼ | 6.1%▼ | 1.17x▼ |
| TEVATEVA Pharmaceutical Industries · Drug manufacturers | $17.3B | 4.3%▼ | – | 12.5%▲ | 7.9%▲ | 2.12x▼ |
| VEEVVeeva Systems · Health information services | $3.2B | 16.3%▲ | 27.3%▲ | 28.7%▲ | 12.5%▲ | – |
| WATWaters · Diagnostics & research | $3.2B | 7%▼ | 0.8%▼ | 25.4%▲ | 20.9%▲ | 0.37x▲ |
| IQVIQVIA · Diagnostics & research | $16.3B | 5.9%▼ | -0.9%▼ | 13.4%▲ | 10.1%▲ | 2.42x▼ |
| IDXXIdexx Laboratories · Diagnostics & research | $4.3B | 10.4%▼ | 19.3%▲ | 31.6%▲ | 61.8%▲ | 0.28x▲ |
| RVMDRevolution Medicines · Biotechnology | $0M | – | – | – | -57.3%▼ | – |
| ILMNIllumina · Diagnostics & research | $4.3B | -0.7%▼ | – | 18.6%▲ | 16%▲ | 0.55x▲ |
| ONCBeOne Medicines · Drug manufacturers | $5.3B | 40.2%▲ | – | 8.4% | 7%▲ | 0.23x▲ |
| CNCCentene · Healthcare plans | $175B | 20%▲ | -302%▼ | -4.4%▼ | -19%▼ | 0.87x▼ |
| BIIBBiogen · Biotechnology | $9.9B | 2.2%▼ | -20.8%▼ | 15.7%▲ | 6%▼ | 0.34x▲ |
| RPRXRoyalty Pharma · Drug manufacturers | $2.4B | 5.1%▼ | -10.2%▼ | 65.6%▲ | 8.2%▲ | 0.92x▼ |
| RMDResmed · Medical devices & instruments | $5.7B | 9.9%▼ | 8.8%▲ | 33.4%▲ | 24.9%▲ | 0.10x▲ |
| MTDMettler Toledo International Inc/ · Diagnostics & research | $4.0B | 4%▼ | 0.7%▼ | 27.8%▲ | 44.4%▲ | – |
| DXCMDexcom · Medical devices & instruments | $4.7B | 15.6%▲ | 45.1%▲ | 19.6%▲ | 21.7%▲ | – |
| ZTSZoetis · Drug manufacturers | $9.5B | 2.3%▼ | 7.5%▲ | 37.8%▲ | 26.9%▲ | 2.65x▼ |
| GEHCGE HealthCare Technologies · Medical devices & instruments | $20.6B | 4.8%▼ | 4.6%▲ | 13.4%▲ | 9.9%▲ | 0.96x▼ |
| ALCALCON · Medical devices & instruments | $10.4B | 4.9%▼ | -3.7%▼ | 13.1%▲ | 4.8%▼ | 0.21x▲ |
| ALNYAlnylam Pharmaceuticals · Drug manufacturers | $3.7B | 65.2%▲ | – | 13.5%▲ | 14.3%▲ | – |
| WSTWest Pharmaceutical Services · Medical devices & instruments | $3.1B | 6.3%▼ | 0.2%▼ | 19%▲ | 16.2%▲ | 0.06x▲ |
| DGXQuest Diagnostics · Diagnostics & research | $11.0B | 11.8%▲ | 13.9%▲ | 14.1%▲ | 11.2%▲ | 0.79x▼ |
| LHLabcorp · Diagnostics & research | $14.0B | 7.2%▼ | 17.5%▲ | 9.9%▲ | 8.9%▲ | 0.65x▼ |
| PHGKoninklijke Philips · Medical devices & instruments | EUR 17.8B | -1%▼ | – | 8%▼ | 7.3%▲ | 0.74x▼ |
| ROIVRoivant Sciences · Drug manufacturers | $8M | -71.6%▼ | – | -6236%▼ | -9.5%▼ | – |
| UTHRUnited Therapeutics · Drug manufacturers | $3.2B | 10.6%▼ | 11.7%▲ | 46.9%▲ | 20.4%▲ | – |
| INCYIncyte · Diagnostics & research | $5.1B | 21.2%▲ | 3845%▲ | 29.5%▲ | 27.8%▲ | – |
| BNTXBioNTech · Biotechnology | EUR 2.9B | 4.3%▼ | – | -49%▼ | -7.1%▼ | – |
| THCTenet Healthcare · Medical care facilities | $21.3B | 3.1%▼ | -41.8%▼ | 16.5%▲ | 13.9%▲ | 3.10x▼ |
| GHGuardant Health · Diagnostics & research | $982M | 32.9%▲ | – | -44.5%▼ | -25.6%▼ | – |
| STESteris · Medical devices & instruments | $5.9B | 8.7%▼ | 27.3%▲ | 18.6%▲ | 11.5%▲ | 0.27x▲ |
| INSMInsmed · Drug manufacturers | $606M | 66.7%▲ | – | -206%▼ | -69.4%▼ | 0.73x▼ |
| VTRSViatris · Drug manufacturers | $14.3B | -3%▼ | – | -18.7%▼ | -8.8%▼ | 0.98x▼ |
| ZBHZimmer Biomet · Medical devices & instruments | $8.2B | 7.2%▼ | -22%▼ | 13.3%▲ | 5.4%▼ | 0.59x▼ |
| MEDPMedpace · Diagnostics & research | $2.5B | 20%▲ | 11.6%▲ | 21.1%▲ | 84.7%▲ | – |
| RVTYRevvity · Diagnostics & research | $2.9B | 3.7%▼ | -10.8%▼ | 12.5%▲ | 3.3%▼ | 0.44x▲ |
| EXELExelixis · Biotechnology | $2.3B | 7%▼ | 50.1%▲ | 37.6%▲ | 35.8%▲ | – |
| ASNDAscendis Pharma A/S · Drug manufacturers | EUR 720M | 98%▲ | – | -18.9%▼ | -58.4%▼ | – |
| SOLVSolventum · Medical devices & instruments | $8.3B | 0.9%▼ | 225%▲ | 26.2%▲ | 19.5%▲ | 1.00x▼ |
| CRLCharles River Laboratories International · Diagnostics & research | $4.0B | -0.9%▼ | -750%▼ | 0.6%▼ | 0.4%▼ | 0.68x▼ |
| ULSUL Solutions · Diagnostics & research | $3.1B | 6.4%▼ | -0.3%▼ | 17.1%▲ | 24.2%▲ | 0.39x▲ |
| NBIXNeurocrine Biosciences · Biotechnology | $2.9B | 21.4%▲ | 40.2%▲ | 21.6%▲ | 15.9%▲ | – |
| JAZZJazz Pharmaceuticals · Drug manufacturers | $4.3B | 4.9%▼ | -164%▼ | -10.1%▼ | -4.6%▼ | 1.24x▼ |
| HALOHalozyme Therapeutics · Biotechnology | $1.4B | 37.6%▲ | -28.6%▼ | 33.6%▲ | 20%▲ | 44x▼ |
| ICLRICON · Diagnostics & research | $8.3B | 0.8%▼ | -69%▼ | 5.4%▼ | 3.4%▼ | 0.31x▲ |
| CORTCorcept Therapeutics · Drug manufacturers | $761M | 12.8%▲ | -29.4%▼ | 5.9%▼ | 6.7%▼ | – |
| BAXBaxter International · Medical devices & instruments | $11.2B | 5.7%▼ | – | -2.7%▼ | -1.8%▼ | 1.54x▼ |
| BBIOBridgeBio Pharma · Drug manufacturers | $502M | 126%▲ | – | -104%▼ | -80.8%▼ | – |
| PENPenumbra · Medical devices & instruments | $1.4B | 17.5%▲ | 1168%▲ | 13.5%▲ | 11.5%▲ | – |
| BTSGBrightSpring Health Services · Medical care facilities | $12.9B | 28.2%▲ | – | 2.3%▼ | 6.5%▼ | 1.34x▼ |
| EHCEncompass Health · Medical care facilities | $5.9B | 10.5%▼ | 24.2%▲ | 17.7%▲ | 16.8%▲ | 1.00x▼ |
| TEMTempus AI · Health information services | $1.3B | 83.4%▲ | – | -19.9%▼ | -13.3%▼ | – |
| SNNSmith & Nephew · Medical devices & instruments | $6.2B | 6.1%▼ | 51.7%▲ | 12.9%▲ | 9%▲ | 0.59x▲ |
| DVADavita · Medical care facilities | $13.6B | 6.5%▼ | -20.2%▼ | 15%▲ | 14.3%▲ | – |
| FMSFresenius Medical Care · Medical care facilities | EUR 19.6B | 1.5%▼ | 60.8%▲ | 9.3%▲ | 7.4%▲ | 0.55x▲ |
| TECHBio-Techne · Biotechnology | $1.2B | -0.4%▼ | 148%▲ | 20.7%▲ | 10.4%▲ | 0.09x▲ |
| RGENRepligen · Biotechnology | $738M | 16.4%▲ | – | 7.5%▼ | 2%▼ | 0.26x▲ |
| ELANElanco Animal Health · Drug manufacturers | $4.7B | 6.2%▼ | -169%▼ | -0.1%▼ | -0%▼ | 0.57x▲ |
| UHSUniversal Health Services · Medical care facilities | $17.4B | 9.7%▼ | 30.4%▲ | 11.5%▲ | 16.2%▲ | 0.65x▼ |
| MOHMolina Healthcare · Healthcare plans | $45.4B | 11.7%▲ | -60%▼ | 1.7%▼ | 9.5%▲ | 0.93x▼ |
| AVTRAvantor · Diagnostics & research | $6.6B | -3.4%▼ | -175%▼ | -3.8%▼ | -2.4%▼ | 0.71x▼ |
| MDGLMadrigal Pharmaceuticals · Drug manufacturers | $958M | 432%▲ | – | -31.3%▼ | -31.6%▼ | 0.56x▲ |
| RDYDR Reddys Laboratories · Drug manufacturers | INR 326B | 16.6%▲ | 2.8% | 22.1%▲ | 19.8%▲ | 0.14x▲ |
| BMRNBiomarin Pharmaceutical · Drug manufacturers | $3.2B | 12.9%▲ | -18.3%▼ | 12.7%▲ | 6%▼ | 0.10x▲ |
| OSCROscar Health · Healthcare plans | $29M | 39%▲ | -1842%▼ | -1386%▼ | -27.1%▼ | 0.44x▲ |
| COOCooper Companies · Medical devices & instruments | $4.1B | 5.1%▼ | -4.4%▼ | 16.7%▲ | 6.1%▼ | 0.30x▲ |
| IBRXImmunityBio · Biotechnology | $113M | 668%▲ | – | -226%▼ | -58.2%▼ | – |
| GMEDGlobus Medical · Medical devices & instruments | $2.9B | 16.7%▲ | 422%▲ | 16.3%▲ | 10%▲ | – |
| ENSGEnsign · Medical care facilities | $5.0B | 18.8%▲ | 15.4%▲ | 8.5%▲ | 9.3%▲ | 0.06x▲ |
| ALGNAlign Technology · Medical devices & instruments | $4.0B | 0.9%▼ | -2.6%▼ | 13.5%▲ | 12.7%▲ | – |
| GKOSGlaukos · Medical devices & instruments | $507M | 32.3%▲ | – | -39.3%▼ | -25.2%▼ | – |
| TWSTTwist Bioscience · Biotechnology | $377M | 20.3%▲ | – | -36.2%▼ | -24.8%▼ | – |
| BIOBio-Rad Laboratories · Diagnostics & research | $2.6B | 0.7%▼ | – | 1.8%▼ | 0.5%▼ | 0.16x▲ |
| KRYSKrystal Biotech · Biotechnology | $389M | 33.9%▲ | 130%▲ | 41.5%▲ | 13.1%▲ | – |
| TXG10x Genomics · Diagnostics & research | $643M | 5.2%▼ | – | -9.5%▼ | -6.9%▼ | – |
| HSICHenry Schein · Medical distribution | $13.2B | 4%▼ | 2.1%▼ | 5%▼ | 8.2%▲ | 0.95x▼ |
| QGENQiagen · Biotechnology | $2.1B | 5.7%▼ | 408%▲ | 22.3%▲ | 8.1%▲ | 0.44x▲ |
| PODDInsulet · Medical devices & instruments | $2.7B | 30.7%▲ | -40.9%▼ | 17.5%▲ | 18.9%▲ | 0.63x▼ |
| CYTKCytokinetics · Drug manufacturers | $88M | 377%▲ | – | -695%▼ | -50.1%▼ | – |
| PTGXProtagonist Therapeutics · Drug manufacturers | $46M | -89.4%▼ | -147%▼ | -344%▼ | -25.4%▼ | – |
| KYMRKymera Therapeutics · Biotechnology | $39M | -16.7%▼ | – | -891%▼ | -21.1%▼ | – |
| CAICaris Life Sciences · Diagnostics & research | $812M | 97%▲ | – | 5.6%▼ | 4.5%▼ | 0.66x▼ |
| BRKRBruker · Diagnostics & research | $3.4B | 2.1%▼ | -108%▼ | 2%▼ | 1.4%▼ | 0.75x▼ |
| AXSMAxsome Therapeutics · Drug manufacturers | $638M | 65.5%▲ | – | -26.1%▼ | -53.6%▼ | 2.13x▼ |
| TGTXTG Therapeutics · Drug manufacturers | $616M | 87.3%▲ | 1812%▲ | 20%▲ | 13.6%▲ | 0.38x▲ |
| ARWRArrowhead Pharmaceuticals · Drug manufacturers | $829M | 23258%▲ | – | 11.9%▲ | 8.3%▲ | – |
| HQYHealthequity · Health information services | $1.3B | 9.5%▼ | 123%▲ | 24.6%▲ | 10%▲ | 0.45x▲ |
| SYRESpyre Therapeutics · Drug manufacturers | $0M | – | – | – | -29.1%▼ | – |
| IONSIonis Pharmaceuticals · Drug manufacturers | $944M | 33.8%▲ | – | -40.4%▼ | -13.9%▼ | 3.60x▼ |
| PACSPACS · Medical care facilities | $5.3B | 29.4%▲ | 244%▲ | 5.9%▼ | 6.8%▲ | 0.26x▲ |
| MSAMSA Safety · Medical devices & instruments | $1.9B | 3.7%▼ | -2.1%▼ | 19.8%▲ | 16.4%▲ | 0.42x▲ |
| PRAXPraxis Precision Medicines · Drug manufacturers | $0M | -100%▼ | – | – | -37.1%▼ | – |
| AMRXAmneal Pharmaceuticals · Drug manufacturers | $3.0B | 8%▼ | – | 13.1%▲ | 14.1%▲ | – |
| CHEChemed · Medical care facilities | $2.5B | 65.3%▲ | -12.2%▼ | 13.4%▲ | 27%▲ | – |
| ALKSAlkermes · Drug manufacturers | $1.5B | -5.2%▼ | -34.2%▼ | 17.2%▲ | 13.1%▲ | 0.00x▲ |
| HIMSHims & Hers Health · Medical care facilities | $2.3B | 59%▲ | 1.8%▼ | 4.5%▼ | 6%▼ | – |
| LNTHLantheus · Diagnostics & research | $1.5B | 0.5%▼ | -25.2%▼ | 20.2%▲ | 16.4%▲ | 0.52x▲ |
| IOVAIovance Biotherapeutics · Biotechnology | $264M | 60.6%▲ | – | -153%▼ | -52.1%▼ | – |
| KNSAKiniksa Pharmaceuticals International · Drug manufacturers | $678M | 60.1%▲ | – | 11.4%▲ | 12.4%▲ | – |
| GRALGRAIL · Diagnostics & research | $147M | 17.2%▲ | – | -382%▼ | -19.8%▼ | – |
| RYTMRhythm Pharmaceuticals · Drug manufacturers | $190M | 45.8%▲ | – | -101%▼ | -51.3%▼ | 0.78x▼ |
| LGNDLigand Pharmaceuticals · Drug manufacturers | $268M | 60.4%▲ | – | 15.3%▲ | 2.7%▼ | 0.44x▲ |
| BLCOBausch & Lomb · Medical devices & instruments | $5.1B | 6.5%▼ | – | 2.2%▼ | 0.9%▼ | 0.78x▼ |
| DOCSDoximity · Health information services | $645M | 13.1%▲ | -12.2%▼ | 33.3%▲ | 22.2%▲ | – |
| HAEHaemonetics · Medical devices & instruments | $1.3B | -2%▼ | -42%▼ | 11.7%▲ | 7.4%▲ | 1.54x▼ |
| RDNTRadNet · Diagnostics & research | $2.0B | 11.5%▲ | -768%▼ | 3%▼ | 2%▼ | 1.00x▼ |
| CGONCG Oncology · Biotechnology | $4M | 255%▲ | – | -4722%▼ | -25.1%▼ | 0.00x▲ |
| TFXTeleflex · Medical devices & instruments | $2.0B | 17.2%▲ | -1400%▼ | 5.9%▼ | 1.9%▼ | 0.85x▼ |
| MIRMMirum Pharmaceuticals · Drug manufacturers | $521M | 54.7%▲ | – | -4.2%▼ | -3.5%▼ | – |
| MMSIMerit Medical Systems · Medical devices & instruments | $1.5B | 11.8%▲ | 6.8%▲ | 12.2%▲ | 7.6%▲ | 0.46x▲ |
| STVNStevanato Group S.p.A. · Medical devices & instruments | EUR 1.2B | 7.4%▼ | 18.7%▲ | 16.8%▲ | 9.9%▲ | 0.31x▲ |
| SHCSotera Health · Medical care facilities | $1.2B | 5.7%▼ | 75.6%▲ | 12.7%▲ | 4.9%▼ | 3.53x▼ |
| TVTXTravere Therapeutics · Drug manufacturers | $491M | 110%▲ | – | -12.8%▼ | -14.1%▼ | – |
| PTCTPTC Therapeutics · Drug manufacturers | $1.7B | 115%▲ | – | 50.1%▲ | 44.9%▲ | – |
| GRFSGrifols · Drug manufacturers | EUR 7.5B | 4.3%▼ | 135%▲ | 16.5%▲ | 7%▲ | 0.41x▲ |
| CRSPCRISPR Therapeutics · Biotechnology | $4M | -90.6%▼ | – | -18934%▼ | -31.4%▼ | 0.00x▲ |
| SRRKScholar Rock · Biotechnology | $0M | – | – | – | -110%▼ | 0.41x▲ |
| MMEDMiniMed · Medical devices & instruments | $3.1B | 14.3%▲ | – | -6.1%▼ | -4.8%▼ | – |
| CONConcentra Group Holdings Parent · Medical care facilities | $2.2B | 13.9%▲ | -0.1%▼ | 15.4%▲ | 13.2%▲ | 3.98x▼ |
| LFSTLifeStance Health · Medical care facilities | $1.4B | 13.9%▲ | – | 1.7%▼ | 1.2%▼ | 0.18x▲ |
| OPCHOption Care Health · Medical care facilities | $5.6B | 13%▲ | -2%▼ | 6%▼ | 12.9%▲ | 0.88x▼ |
| BLLNBillionToOne · Diagnostics & research | $305M | 100%▲ | – | 5.3%▼ | 2.7%▼ | 0.12x▲ |
| HTFLHeartflow · Medical devices & instruments | $176M | 39.9%▲ | – | -36.4%▼ | -20.2%▼ | – |
| ITGRInteger · Medical devices & instruments | $1.9B | 8%▼ | -14.3%▼ | 11.9%▲ | 7%▲ | 0.68x▼ |
| DNTHDianthus Therapeutics · Drug manufacturers | $2M | -67.3%▼ | – | -8739%▼ | -35.6%▼ | – |
| LIVNLivaNova · Medical devices & instruments | $1.4B | 10.7%▼ | -483%▼ | 14.4%▲ | 11.1%▲ | 0.31x▲ |
| ADPTAdaptive Biotechnologies · Biotechnology | $277M | 54.8%▲ | – | -20.6%▼ | -13.5%▼ | 0.60x▼ |
| ICUIIcu Medical · Medical devices & instruments | $2.2B | -6.3%▼ | – | 1.9%▼ | 1.2%▼ | 0.60x▼ |
| INDVIndivior Pharmaceuticals · Drug manufacturers | $1.2B | 4.3%▼ | 2900%▲ | 21.1%▲ | 91.3%▲ | – |
| ABCLAbCellera Biologics · Drug manufacturers | $75M | 161%▲ | – | -289%▼ | -16.8%▼ | – |
| LEGNLegend Biotech · Drug manufacturers | $1.0B | 64%▲ | – | -13.3%▼ | -12.4%▼ | 0.32x▲ |
| RLAYRelay Therapeutics · Biotechnology | $15M | 53.4%▲ | – | -1972%▼ | -50.8%▼ | – |
| TNGXTango Therapeutics · Drug manufacturers | $62M | 48.3%▲ | – | -178%▼ | -29.5%▼ | – |
| NHCNational Healthcare · Medical care facilities | $1.5B | 16.1%▲ | 17.7%▲ | 8.5%▲ | 10.1%▲ | 0.04x▲ |
| NVSTEnvista · Medical devices & instruments | $2.7B | 8.3%▼ | – | 7.9%▼ | 4.5%▼ | 0.47x▲ |
| OGNOrganon · Drug manufacturers | $6.2B | -2.9%▼ | -78.4%▼ | 14.9%▲ | 8.9%▲ | 11x▼ |
| TLXTelix Pharmaceuticals · Drug manufacturers | $804M | 55.6%▲ | -121%▼ | 3.7%▼ | 3.2%▼ | 0.98x▼ |
| IRTCiRhythm · Medical devices & instruments | $747M | 26.2%▲ | – | -7.7%▼ | -6.6%▼ | – |
| VCYTVeracyte · Diagnostics & research | $517M | 16%▲ | 175%▲ | 11.2%▲ | 4.3%▼ | – |
| TARSTarsus Pharmaceuticals · Biotechnology | $451M | 147%▲ | – | -15.7%▼ | -16.6%▼ | 0.21x▲ |
| CDNACareDx · Diagnostics & research | $380M | 13.8%▲ | -141%▼ | -8.1%▼ | -9.5%▼ | – |
| AMLXAmylyx Pharmaceuticals · Drug manufacturers | $0M | -100%▼ | – | – | -49.5%▼ | – |
| ARQTArcutis Biotherapeutics · Drug manufacturers | $376M | 91.3%▲ | – | -3.3%▼ | -4%▼ | 0.58x▲ |
| ACADAcadia Pharmaceuticals · Drug manufacturers | $1.1B | 11.9%▲ | 72.7%▲ | 9.8%▲ | 8.1%▲ | – |
| IDYAIDEAYA Biosciences · Drug manufacturers | $219M | 3024%▲ | – | -72.8%▼ | -15.2%▼ | – |
| XENEXenon Pharmaceuticals · Drug manufacturers | $8M | – | – | -4974%▼ | -63.1%▼ | – |
| VKTXViking Therapeutics · Drug manufacturers | $0M | – | – | – | -61.5%▼ | – |
| PLSEPulse Biosciences · Medical devices & instruments | $0M | – | – | -21983%▼ | -88.8%▼ | – |
| WRBYWarby Parker · Medical devices & instruments | $872M | 13%▲ | – | -0.6%▼ | -0.9%▼ | – |
| LQDALiquidia · Drug manufacturers | $158M | 1031%▲ | – | -32.5%▼ | -26.7%▼ | – |
| ACHCAcadia Healthcare · Medical care facilities | $3.3B | 5%▼ | -531%▼ | – | – | 1.28x▼ |
| ATRCAtriCure · Medical devices & instruments | $535M | 14.9%▲ | – | -1.8%▼ | -1.6%▼ | 0.13x▲ |
| RCUSArcus Biosciences · Drug manufacturers | $33M | -35.3%▼ | – | -1170%▼ | -42.5%▼ | 0.16x▲ |
| DNLIDenali Therapeutics · Biotechnology | $0M | – | – | – | -53.1%▼ | – |
| PRVAPrivia Health · Medical care facilities | $2.1B | 22.3%▲ | 59.3%▲ | 1.6%▼ | 4.3%▼ | – |
| AVAHAveanna Healthcare · Medical care facilities | $2.4B | 20.2%▲ | – | 10.5%▲ | 16.2%▲ | 6.68x▼ |
| PGENPrecigen · Drug manufacturers | $10M | 147%▲ | – | -1141%▼ | -93.5%▼ | 4.46x▼ |
| TMDXTransMedics · Medical devices & instruments | $605M | 37.1%▲ | 437%▲ | 17.9%▲ | 11.1%▲ | – |
| NEOGNeogen · Diagnostics & research | $870M | -2.7%▼ | – | -2.5%▼ | -0.7%▼ | 0.38x▲ |
| NRIXNurix Therapeutics · Drug manufacturers | $84M | 54%▲ | – | -340%▼ | -47.5%▼ | – |
| CLOVClover Health Investments · Healthcare plans | $1.9B | 40.3%▲ | – | -4.4%▼ | -25.7%▼ | – |
| ZLABZai Lab · Drug manufacturers | $457M | 15%▲ | – | -50.2%▼ | -30.3%▼ | – |
| GRDNGuardian Pharmacy Services · Pharmaceutical retailers | $1.4B | 17.9%▲ | – | 5%▼ | 28.9%▲ | 0.00x▲ |
| MRVIMaravai Lifesciences · Drug manufacturers | $186M | -28.3%▼ | – | -116%▼ | -29.7%▼ | 1.37x▼ |
| BEAMBeam Therapeutics · Biotechnology | $140M | 120%▲ | – | -275%▼ | -27.7%▼ | – |
| BKDBrookdale Senior Living · Medical care facilities | $3.2B | 2.2%▼ | – | 0.4%▼ | 0.3%▼ | – |
| SUPNSupernus Pharmaceuticals · Drug manufacturers | $719M | 8.6%▼ | -152%▼ | -8.7%▼ | -5.6%▼ | – |
| HCMHUTCHMED (China) · Drug manufacturers | $549M | -13%▼ | 1111%▲ | -7.1%▼ | -2.7%▼ | 0.08x▲ |
| ADMAADMA Biologics · Biotechnology | $510M | 19.6%▲ | -25.7%▼ | 37.5%▲ | 34.5%▲ | 0.15x▲ |
| NAMSNewAmsterdam Pharma · Drug manufacturers | $23M | -50.6%▼ | – | -1003%▼ | -33%▼ | – |
| PBHPrestige Consumer Healthcare · Drug manufacturers | $1.1B | -4.3%▼ | -11.3%▼ | 28.4%▲ | 9.2%▲ | 0.53x▲ |
| UFPTUfp Technologies · Medical devices & instruments | $603M | 19.5%▲ | 15.8%▲ | 15.3%▲ | 15.9%▲ | 0.32x▲ |
| PRGOPerrigo · Drug manufacturers | $4.3B | -2.8%▼ | – | -26.4%▼ | -14.9%▼ | 1.24x▼ |
| BHCBausch Health Companies · Drug manufacturers | $10.3B | 6.7%▼ | – | 17.7%▲ | 8.2%▲ | – |
| HRMYHarmony Biosciences · Drug manufacturers | $868M | 21.5%▲ | 9.1%▲ | 24%▲ | 20.4%▲ | 0.19x▲ |
| MDPediatrix Medical · Medical care facilities | $1.9B | -4.9%▼ | – | 10.9%▲ | 11.7%▲ | 0.66x▼ |
| AUPHAurinia Pharmaceuticals · Drug manufacturers | $283M | 20.4%▲ | 4893%▲ | 37.1%▲ | 15.9%▲ | – |
| CLDXCelldex Therapeutics · Diagnostics & research | $2M | -78%▼ | – | -18600%▼ | -54%▼ | – |
| ADUSAddus HomeCare · Medical care facilities | $1.4B | 23.2%▲ | 30.3%▲ | 9.7%▲ | 10.8%▲ | 0.11x▲ |
| NEONeogenomics · Diagnostics & research | $727M | 10.1%▼ | – | -15.9%▼ | -9.1%▼ | 0.41x▲ |
| PGNYProgyny · Medical care facilities | $1.3B | 10.4%▼ | 7.7%▲ | 6.6%▼ | 15.8%▲ | – |
| NVAXNovavax · Biotechnology | $1.1B | 64.7%▲ | – | 40.3%▲ | 63.2%▲ | – |
| AXGNAxogen · Medical devices & instruments | $225M | 20.2%▲ | – | -3.5%▼ | -4%▼ | 0.38x▲ |
| VRDNViridian Therapeutics · Drug manufacturers | $71M | 23360%▲ | – | -513%▼ | -43.9%▼ | – |
| VCELVericel · Biotechnology | $276M | 16.5%▲ | 59.4%▲ | 4%▼ | 2.5%▼ | – |
| BCRXBiocryst Pharmaceuticals · Biotechnology | $875M | 94.1%▲ | – | 39%▲ | 107%▲ | – |
| FTREFortrea · Diagnostics & research | $2.7B | 1%▼ | – | -32%▼ | -48.4%▼ | 1.87x▼ |
| IMNMImmunome · Drug manufacturers | $7M | -23.2%▼ | – | -3229%▼ | -35.1%▼ | – |
| WGSGeneDx · Medical care facilities | $428M | 40%▲ | – | -3.1%▼ | -3.2%▼ | 0.17x▲ |
| BFLYButterfly Network · Medical devices & instruments | $98M | 19%▲ | – | -88.5%▼ | -37.3%▼ | – |